This clinical trial is testing whether adding a newer, targeted drug to a standard three-drug combination could produce stronger responses in patients with newly diagnosed myeloma who were eligible for a stem cell transplant.
Breast cancer for some relapsing patients / 2 patients (12 targeted)
This breast cancer trial aims to find out whether treatment with a new kind of endocrine therapy is effective for patients who have relapsed after surgery (or after surgery combined with chemotherapy or radiotherapy). To date two patients have been recruited, with 43 patients being screened for participation.